Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2760501rdf:typepubmed:Citationlld:pubmed
pubmed-article:2760501lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:2760501lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2760501lifeskim:mentionsumls-concept:C0678823lld:lifeskim
pubmed-article:2760501lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:2760501lifeskim:mentionsumls-concept:C0743223lld:lifeskim
pubmed-article:2760501lifeskim:mentionsumls-concept:C1112870lld:lifeskim
pubmed-article:2760501lifeskim:mentionsumls-concept:C0877825lld:lifeskim
pubmed-article:2760501pubmed:issue3lld:pubmed
pubmed-article:2760501pubmed:dateCreated1989-9-19lld:pubmed
pubmed-article:2760501pubmed:abstractTextThe tissular distribution of pentamidine mesylate (4 mg/kg as free base) after intravenous, intramuscular, and aerosol administration in healthy rats was examined. Pentamidine levels in the plasma, lungs, liver, kidneys, and other organs were determined by high-performance liquid chromatography. Pentamidine was undetectable in the plasma after day 5. At day 1, the injected groups had high concentrations of the drug in the kidneys (32-34 micrograms/g) and spleen with much lower concentrations in the lungs and the liver (3.12-5.70 micrograms/g and 1.64-2.19 micrograms/g, respectively). Aerosol delivery of pentamidine produced negligible extrapulmonary drug levels (3.29 micrograms/g in kidneys at day 1) and high sustained pulmonary levels throughout the 60 d of the study (range 5.42-19.62 micrograms/g). The half-time of elimination was longer in the lungs and kidneys (29-45 d) than in the liver (1.4-7.0 d) regardless of the mode of administration.lld:pubmed
pubmed-article:2760501pubmed:languageenglld:pubmed
pubmed-article:2760501pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2760501pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2760501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2760501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2760501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2760501pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2760501pubmed:statusMEDLINElld:pubmed
pubmed-article:2760501pubmed:monthSeplld:pubmed
pubmed-article:2760501pubmed:issn0022-1899lld:pubmed
pubmed-article:2760501pubmed:authorpubmed-author:FarinottiRRlld:pubmed
pubmed-article:2760501pubmed:authorpubmed-author:GuillotEElld:pubmed
pubmed-article:2760501pubmed:authorpubmed-author:GirardP MPMlld:pubmed
pubmed-article:2760501pubmed:authorpubmed-author:TrouvinJ HJHlld:pubmed
pubmed-article:2760501pubmed:authorpubmed-author:CertainAAlld:pubmed
pubmed-article:2760501pubmed:authorpubmed-author:PascaudM BMBlld:pubmed
pubmed-article:2760501pubmed:issnTypePrintlld:pubmed
pubmed-article:2760501pubmed:volume160lld:pubmed
pubmed-article:2760501pubmed:ownerNLMlld:pubmed
pubmed-article:2760501pubmed:authorsCompleteYlld:pubmed
pubmed-article:2760501pubmed:pagination507-12lld:pubmed
pubmed-article:2760501pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:meshHeadingpubmed-meshheading:2760501-...lld:pubmed
pubmed-article:2760501pubmed:year1989lld:pubmed
pubmed-article:2760501pubmed:articleTitleComparison of tissular disposition of pentamidine mesylate in the rat after aerosol or parenteral administration.lld:pubmed
pubmed-article:2760501pubmed:affiliationInstitut National de la Santé et de la Recherche Médicale, Unité 13, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris, France.lld:pubmed
pubmed-article:2760501pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2760501pubmed:publicationTypeComparative Studylld:pubmed